Humana Posts MA Boost, Centene Frustrated by CMS Rules and Medicaid Unwinding

Humana has revised its outlook, confident that its expected Medicare Advantage enrollment will increase even more than it originally anticipated in 2023. But Centene has reported the opposite, expecting to lose money in Medicare Advantage and from Medicaid redeterminations. Centene released its first quarter (Q1) corporate reports on...